Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 985723711 | 9857237 | 11 | F | 20130725 | 20160808 | 20140130 | 20160817 | EXP | JP-GILEAD-2014-0093240 | GILEAD | 36.00 | YR | A | M | Y | 75.50000 | KG | 20160817 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 985723711 | 9857237 | 1 | PS | ELVITEGRAVIR/EMTRICITABINE/TENOFOVIR DF/COBICISTAT | COBICISTATELVITEGRAVIREMTRICITABINETENOFOVIR | 1 | Oral | 1 DF, QD | 70 | DF | Y | 203100 | 1 | DF | TABLET | QD | |||
| 985723711 | 9857237 | 2 | SS | EMTRICITABINE/TENOFOVIR DF | EMTRICITABINE | 1 | Oral | 1 DF, QD | 2256 | DF | 0 | 1 | DF | TABLET | QD | ||||
| 985723711 | 9857237 | 3 | SS | EMTRICITABINE/TENOFOVIR DF | EMTRICITABINE | 1 | Oral | 1 DF, QD | 2256 | DF | 0 | 1 | DF | TABLET | QD | ||||
| 985723711 | 9857237 | 4 | SS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 800 MG, QD | Y | 0 | 800 | MG | QD | ||||||
| 985723711 | 9857237 | 5 | C | CROSS EIGHT M | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous drip | 1000 IU, QD | 0 | 1000 | IU | INJECTION | QD | ||||||
| 985723711 | 9857237 | 6 | C | CROSS EIGHT M | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous drip | 2000 IU, QD | 0 | 2000 | IU | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 985723711 | 9857237 | 1 | HIV infection |
| 985723711 | 9857237 | 2 | HIV infection |
| 985723711 | 9857237 | 4 | HIV infection |
| 985723711 | 9857237 | 5 | Factor VIII deficiency |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 985723711 | 9857237 | HO |
| 985723711 | 9857237 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 985723711 | 9857237 | Dizziness | |
| 985723711 | 9857237 | Haemorrhage subcutaneous | |
| 985723711 | 9857237 | Mucosal haemorrhage | |
| 985723711 | 9857237 | Nausea | |
| 985723711 | 9857237 | Pyrexia | |
| 985723711 | 9857237 | Rash | |
| 985723711 | 9857237 | Renal tubular disorder | |
| 985723711 | 9857237 | Upper respiratory tract inflammation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 985723711 | 9857237 | 1 | 20130725 | 20131204 | 0 | |
| 985723711 | 9857237 | 2 | 20131205 | 0 | ||
| 985723711 | 9857237 | 3 | 20070521 | 20130724 | 0 | |
| 985723711 | 9857237 | 4 | 20131205 | 20140625 | 0 | |
| 985723711 | 9857237 | 5 | 20140401 | 20150216 | 0 |